Home
    Registration
    Accommodation
    Webcasting
    Contact
     Home
     Welcome Note
     Our Vision
     Committees
     Industry Advisory Board (IAB)
     Scientific Programme
         Satellite Symposia
     Timetable
     CME
         CME Certificate
     Abstract Submission
         Poster Presentations
         Poster Presentation Guidelines
         Best Abstracts Competition
     Registration
         Accompanying Persons Program
         Invitation Letter
     Accommodation
         Hilton Prague Hotel
         Hilton Prague Old Town Hotel
         Corinthia Hotel Prague
         Clarion Congress Hotel
         Panorama Hotel Prague
     Sponsors
     Sponsorship & Exhibition
         Sponsorship Categories
     General Information
         Before you travel...
     About Prague
         Transportation
         Hints and Tips
     CODHy 2006
     CODHy 2008
     CODHy 2008 Webcasting
     CODHy 2008 Abstract Winners
     CODHy 2010 Webcasting
     CODHy Latin America
     CODHy Asia Pacific
     Partners
     Contact Us
The 3rd World Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

Hilton Hotel, Prague, Czech Republic, May 13-16, 2010
 
  Diabetes Care Table of Contents Print

Introduction

Introduction to the Second World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): Dilemmas in clinical practice
Itamar Raz

Diabetes Care 2009;32 S149-S150
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S149
 

Progression/Prevention

Defining and Characterizing the Progression of Type 2 Diabetes
Vivian A. Fonseca

Diabetes Care 2009;32 S151-S156
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S151

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Ralph A. DeFronzo and Devjit Tripathy

Diabetes Care 2009;32 S157-S163
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S157

Viewpoints on the Way to a Consensus Session: Where does insulin resistance start? The liver
Gianluca Perseghin

Diabetes Care 2009;32 S164-S167
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S164

Viewpoints on the Way to the Consensus Session: Where does insulin resistance start? The adipose tissue
Patricia Iozzo

Diabetes Care 2009;32 S168-S173
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S168

Where Does Insulin Resistance Start?: The brain
Uberto Pagotto

Diabetes Care 2009;32 S174-S177
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S174

Goals of Treatment for Type 2 Diabetes: β-Cell preservation for glycemic control
Piero Marchetti, Roberto Lupi, Silvia Del Guerra, Marco Bugliani, Valentina D'Aleo, Margherita Occhipinti, Ugo Boggi, Lorella Marselli, and Matilde Masini

Diabetes Care 2009;32 S178-S183
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S178

Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 Diabetes: Pro pharmacologic therapy
Alan J. Garber

Diabetes Care 2009;32 S184-S188
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S184

Nonpharmacologic Therapy and Exercise in the Prevention of Type 2 Diabetes
Jaakko Tuomilehto

Diabetes Care 2009;32 S189-S193
http://care.diabetesjournals.org/cgi/content/abstract/32/suppl_2/S189

Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes
Muhammad A. Abdul-Ghani and Ralph A. DeFronzo

Diabetes Care 2009;32 S194-S198
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S194

Target for Glycemic Control: Concentrating on glucose
Louis Monnier and Claude Colette

Diabetes Care 2009;32 S199-S204
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S199

Self-Monitoring of Blood Glucose as Part of the Integral Care of Type 2 Diabetes
Eleni I. Boutati and Sotirios A. Raptis

Diabetes Care 2009;32 S205-S210
http://care.diabetesjournals.org/cgi/content/abstract/32/suppl_2/S205

Telemedical Artificial Pancreas: PARIS (Páncreas Artificial Telemédico Inteligente) research project
Alberto de Leiva, María Elena Hernando, and on behalf of EDUAB-HSP and GBT-UPM

Treatment

Changing the Treatment Paradigm for Type 2 Diabetes
Stefano Del Prato, Giuseppe Penno, and Roberto Miccoli

Diabetes Care 2009;32 S217-S222
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S217

Incretin-Based Therapies: Viewpoints on the way to consensus
Michael. A. Nauck, Tina Vilsbøll, Baptist Gallwitz, Alan Garber, and Sten Madsbad

Diabetes Care 2009;32 S223-S231
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S223

Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes
Antonio Ceriello and Roberto Testa

Diabetes Care 2009;32 S232-S236
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S232

Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration
Bart Staels and Vivian A. Fonseca

Diabetes Care 2009;32 S237-S245
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S237

β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
Simona Cernea, Raffaella Buzzetti, and Paolo Pozzilli

Diabetes Care 2009;32 S246-S252
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S246

Insulin Therapy for Type 2 Diabetes
Sanne G. Swinnen, Joost B. Hoekstra, and J. Hans DeVries

Diabetes Care 2009;32 S253-S259
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S253

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
Reinhard G. Bretzel, Michael Eckhard, Wolfgang Landgraf, David R. Owens, and Thomas Linn

Diabetes Care 2009;32 S260-S265
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S260

Early Insulin Treatment in Type 2 Diabetes: What are the pros?
Luigi F. Meneghini

Diabetes Care 2009;32 S266-S269
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S266

Early Insulin Use in Type 2 Diabetes: What are the cons?
Jean-Louis Chiasson

Hypertension and Diabetes Debates

How to Define Prehypertension in Diabetes/Metabolic Syndrome
Avshalom Leibowitz and Ehud Grossman

Diabetes Care 2009;32 S275-S279
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S275

Should We Treat Prehypertension in Diabetes?: What are the cons?
Ehud Grossman

Diabetes Care 2009;32 S280-S283
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S280

Treatment of Prehypertension in Diabetes and Metabolic Syndrome: What are the pros?
Julian Segura and Luis M. Ruilope

Diabetes Care 2009;32 S284-S289
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S284

Hypertension and Diabetes: Should We Treat Early Surrogates?: What are the cons?
Peter M. Nilsson

Diabetes Care 2009;32 S290-S293
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S290

Hypertension and Diabetes: What are the pros to treating early surrogates?
Roland E. Schmieder

Diabetes Care 2009;32 S294-S297
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S294

Should 24-h Ambulatory Blood Pressure Monitoring Be Done in Every Patient With Diabetes?
Gianfranco Parati and Grzegorz Bilo

Diabetes Care 2009;32 S298-S304
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S298

Should White-Coat Hypertension in Diabetes Be Treated? Pro
Giuseppe Mancia, Roberto Sega, Michele Bombelli, Fosca Quarti-Trevano, Rita Facchetti, and Guido Grassi

Diabetes Care 2009;32 S305-S309
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S305

White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
Michael Bursztyn and Iddo Z. Ben-Dov

Diabetes and Cardiovascular Disease

Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
Daniele Versari, Elena Daghini, Agostino Virdis, Lorenzo Ghiadoni, and Stefano Taddei

Diabetes Care 2009;32 S314-S321
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S314

Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes: Understanding and implementing the International Diabetes Federation guidelines
Baptist Gallwitz

Diabetes Care 2009;32 S322-S325
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S322

The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
Oliver Schnell, Wolfgang Otter, and Eberhard Standl

Diabetes Care 2009;32 S326-S330
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S326

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes
Jaime A. Davidson and Christopher G. Parkin

Diabetes Care 2009;32 S331-S333
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S331

Glucose Control and Cardiovascular Disease: Is it important? No
Ignacio Conget and Marga Giménez

Diabetes Care 2009;32 S334-S336
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S334

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
Sameer A. Kassem and Itamar Raz

Diabetes Care 2009;32 S337-S341
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S337

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
Cristina Bianchi, Roberto Miccoli, Giuseppe Daniele, Giuseppe Penno, and Stefano Del Prato

Diabetes Care 2009;32 S342-S348
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S342

Shifting the Disease Management Paradigm From Glucose: What are the pros?
Alin Stirban, Diethelm Tschoepe, and Bernd Stratmann

Diabetes Care 2009;32 S349-S352
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S349

Shifting the Disease Management Paradigm From Glucose: What are the cons?
Markolf Hanefeld, Stefan R. Bornstein, and Frank Pistrosch

Diabetes Care 2009;32 S353-S356
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S353

A Summary of the ADVANCE Trial
Simon R. Heller and on behalf of the ADVANCE Collaborative Group

Obesity and Lipids

Adipocytokines and Insulin Resistance: The possible role of lipocalin-2, retinol binding protein-4, and adiponectin
Eduardo Esteve, Wifredo Ricart, and José Manuel Fernández-Real

Diabetes Care 2009;32 S362-S367
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S362

Diabetes Surgery: A New Approach to an Old Disease
Francesco Rubino, Tracy-Ann Moo, Daniel J. Rosen, Greg F. Dakin, and Alfons Pomp

Diabetes Care 2009;32 S368-S372
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S368

Triglycerides and HDL Cholesterol: Stars or second leads in diabetes?
Rafael Bitzur, Hofit Cohen, Yehuda Kamari, Aviv Shaish, and Dror Harats

Diabetes Care 2009;32 S373-S377
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S373

Should All Diabetic Patients Be Treated With a Statin?
Yehuda Kamari, Rafael Bitzur, Hofit Cohen, Aviv Shaish, and Dror Harats

Diabetes Care 2009;32 S378-S383
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S378

American Diabetes Association Indications for Statins in Diabetes: Is there evidence?
Roy Eldor and Itamar Raz

Diabetes Care 2009;32 S384-S391
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S384

Fat or Fit: What Is More Important?
Vojtech Hainer, Hermann Toplak, and Vladimír Stich

Diabetes Care 2009;32 S392-S397
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S392

Obesity in Elderly Subjects: In sheep's clothing perhaps, but still a wolf!
Etty Osher and Naftali Stern

Diabetes Care 2009;32 S398-S402
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S398

Obesity in the Elderly Diabetic Patient: Is weight loss beneficial? No
Ioannis Kyrou and Constantine Tsigos

Diagnosis and Treatment of Microvascular Disease

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
Mordchai Ravid

Diabetes Care 2009;32 S410-S413
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S410

Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?
Dan Ziegler

Diabetes Care 2009;32 S414-S419
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S414

Microvascular Complications in Diabetic Erectile Dysfunction: Do we need other alternatives?
Yoram Vardi

Smoking

Smoking Cessation: It Is Never Too Late
Peter M. Nilsson and Karl-Olov Fagerström

Diabetes Care 2009;32 S423-S425
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S423

Why Won't Our Patients Stop Smoking?: The power of nicotine addiction
David M. Mannino

Diabetes Care 2009;32 S426-S428
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S426

Smoking Amplifies Cardiovascular Risk in Patients With Hypertension and Diabetes
Robert H. Fagard

Diabetes Care 2009;32 S429-S431
http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S429


Home   
Copyright © 2007 Comtecmed.com. All rights reserved.   The website was last updated on 08/26/2010 Created by    WebStudio.co.il